Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University of Virginia
Age
18–any
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Patients or volunteers with or without a history of melanoma.
One or more palpable skin or subcutaneous lesions for which at least one of the following is true:
* A tissue diagnosis has been made for the lesion(s) in question, by prior cytologic or histologic evaluation (Category A1).
* A tissue diagnosis will be obtained for the lesion(s) in question by cytologic or histologic evaluation (Category A2).
* A tissue diagnosis is not available, but a clinical diagnosis of melanoma or benign lesion is available with a high degree of confidence. Examples are hemangiomas, skin tags, seborrheic keratoses, dermatofibromas, lipomas, or growing pigmented skin lesions that are comparable to other cutaneous metastases of melanoma in the same patient (Category B).
All patients must have the ability and willingness to give informed consent and must be age 18 years or older at the time of study entry.
You may not be if
Known or suspected allergy to the adhesive skin markers or water-soluble ink used for the labeling of lesions.
Very fragile skin that may be susceptible to injury from adhesive markers.
Patients in whom there is a medical contraindication or potential problem in complying with the requirements of the protocol, in the opinion of the investigator.
Clareo Health | Pilot Study of Infrared Imaging of Cutaneous Melanoma
